NM NeuroQ 3.75*

Aiding in the differential diagnosis of dementia

The NM NeuroQ 3.75 application is designed to help clinicians perform a quantitative analysis of FDG-PET brain scans. The application compares the regional brain activity in an individual scan to activity values derived from a group of asymptomatic control subjects. It analyzes the distribution of FDG-PET in individual scans, as sometimes it’s hard to detect differences between two PET scans on the same patient taken at different points in time.

NeuroQ 3.75 thumbnail

Benefits

  • 3D surface projections display.
  • Ability to write out comparison values to an excel spreadsheet.
  • Automated analysis and powerful tool to assist clinicians with interpretations of brain PET scans.
  • Helps clinicians to detect clinically meaningful abnormalities of regional brain metabolism.
  • NeuroQ brain SPECT analysis option (HMPAO normal database).

*NeuroQ is a trademark of Syntermed.

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

You are entering a Philips Healthcare Australia website
Please select the checkbox

The information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).

By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.

Continue Cancel